Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation

Saved in:
Bibliographic Details
Published in:ImmunoTargets and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301675501355008
collection WordPress RSS
FRELIP Feed Integration
container_title ImmunoTargets and Therapy
description
discipline_display Allergology and Immunology
discipline_facet Allergology and Immunology
format Online Article
RSS Article
genre Journal Article
id rss_article:84510
institution FRELIP
journal_source_facet ImmunoTargets and Therapy
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
Allergology and Immunology
General
Allergology and Immunology
sub_discipline_display General
sub_discipline_facet General
subject_display Allergology and Immunology
General
Allergology and Immunology
Allergology and Immunology
General
Allergology and Immunology
subject_facet Allergology and Immunology
General
Allergology and Immunology
title Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_auth Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_full Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_fullStr Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_full_unstemmed Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_short Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_sort kasugamycin inhibits melanoma lung metastasis and chi3l1-driven m2-like tumor-associated macrophage differentiation
topic Allergology and Immunology
General
Allergology and Immunology
url https://www.dovepress.com/kasugamycin-inhibits-melanoma-lung-metastasis-and-chi3l1-driven-m2-lik-peer-reviewed-fulltext-article-ITT